RxDoctor Payments Data

Ashu Goyle, DO

Pain Medicine · Scottsdale, AZNPI 1942339551

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,131 of the $10,467 with a category attached, or 68.1%. 24 manufacturers reported payments, led by Abbott at 36.2% of the total. Reporting peaked in 2019 at $3,112 and has fallen 94.9% since, to $158 in 2025.

$10,467in general payments, 2019–2025

Across 157 payments — averaging $66.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Nevro Corp.$3K
  • GRT US Holding, Inc.$2K
  • Si-bone, Inc.$471
  • Avanos Medical$357
  • Medtronic$307
  • plus $851 from 18 others
$16in research payments, 2019–2025

Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$16

What the payments were for

  • Speaking & faculty fees$2,00019%
  • Travel & lodging$1,33613%
  • Food & beverage$7,13168%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,467 in reported general payments places this provider in the 70th percentile of 180 pain medicine providers in Arizona.

See all pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$503,831
Medicare patients
650
Services billed
11,668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin101$1,290
Celecoxib19$767
Tizanidine Hcl139$731
Methylprednisolone104$728
Duloxetine Hcl17$386
Tramadol Hcl51$253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$184
Baclofen17$132

Paid to pharmacies, not to this prescriber.

Other pain medicine in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →